FHIR Release 3 (STU) CI-Build

This page is part of the FHIR Specification (v3.0.2: STU 3). The current version which supercedes this version is 5.0.0 . For a full list Continuous Integration Build of available versions, see FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions icon . Page versions: R5 R4B R4 R3

Maturity Level : 1
Responsible Owner: Clinical Genomics icon Work Group Ballot Standards Status : Trial Use

Table The era of Contents Background Overview Sequence Resource Observation-genetics Profile DiagnosticReport-genetics Profile ProcedureRequest-genetics Profile HLA genotyping results Profile Relationship among Sequence resource precision medicine-- an emerging approach for disease treatment and genetics profiles HL7 Domain Analysis Model Use Cases Other Genomics Use Cases Clinical Genomics Apps Appendix 1: From DSTU2 Genomics to STU3 10.8 Background Rapid advances prevention that takes into account individual variability in sequencing technologies, clinical genetics tests for whole genome genes, environment, and exome sequencing are allowing sophisticated genetics testing to be used lifestyle for each person-- is upon us.

Precision medicine is fueled by providers and patients the amazing technological advancements in clinical decisions. Results from such tests are used genomics, making it possible (and feasible) to identify distinct undertake broad genetic variants that may contribute to syndromes, conditions and/or predictive responses to treatments. The implementation testing on an individual in a clinically useful timeframe. Whereas not so long ago genomics was primarily of precision medicine will depend upon having concern to bioinformaticists interacting with such artifacts as alignment (e.g., BAM, CRAM) and variant calling (e.g., VCF) data to diagnose patients, choose medications, files, we are now seeing tremendous interest across the clinical community for integrating genomics findings and predict recommendations into the course of disease EHR and care, but will require into the care process. To that end, the HL7 Clinical Genomics Work Group is developing a set of standards and effective user interfaces. for reporting structured genomic data using FHIR.

A current technical challenge exists in interoperability, the ability to access and share clinical and genetics data. The challenges of interoperability includes collection, coding, and retrieval to scale. An individual's genetic data set is large, complex large and complex, and therefore requires curation. Unfortunately, incompatible systems that can manage the size and nomenclatures make sense of the complexity. Unfortunately, due to a lack of widely adopted standards, these systems are already in use. often incompatible. A standards-based ontology approach to data exchange that could be adopted to integrate both genetic data and clinical information systems will be crucial to accelerating the integration of precision medicine and to make sense of genetic testing results in a complete clinical context.

One approach for collecting, coding, and retrieving genetics data comes from the Global Alliance for The Clinical Genomics and Health Work Group icon ( GA4GH ). The GA4GH organization has built and is refining an API and data model for the exchange of full sequence genomic information across multiple research organizations and platforms. The GA4GH focuses on supports the needs of researchers. A second approach is evolving from HL7 through FHIR . FHIR is attractive because it is relatively easy to implement because it is comprised of a set of modular components called resources, which can be easily and incrementally assembled into working systems. The clinical requirements for genetics data is, relative mission to genomics research needs, utilitarian and reductive because it is about distilling create and extracting particular genetics data produced promote its standards by ever more sophisticated testing for use at the point-of-care. This has made FHIR a very functional framework to initiate an interoperable clinical genetics data standardization to which multiple stakeholders have contributed to this guide. FHIR DSTU2 introduced a standard genetics profile that applies to the FHIR Observation resource. Using this profile, Observation payloads can return genetic testing results in a standardized manner. Extending Observations rather than creating a new, dedicated FHIR genetics data resource is consistent with the FHIR community mandate because it only adds new resources to an existing resource library when there is a compelling case to do so. We provide enabling the case to add a Sequence resource in this specification. 10.8 Overview STU3 moves beyond FHIR DSTU2 Standard Genetics profile on Observation allowing increased granularity and less ambiguity by creating a new resource to be called Sequence . This resource will be used to hold clinically relevant sequence semantically meaningful exchange of data between parties interested in a manner that is both efficient and versatile integrating new clinical, personal, and as yet undefined types of population genomic information and other -omics data that will soon be commonly entered into family health records for clinical use. Sequence will be leveraged by other FHIR resources, including Observation. This is consistent with how all FHIR resources are designed and used. The September 2014 Informative Ballot (“HL7 Clinical Genomics, Domain Analysis Model: Clinical Sequencing Release 1”) provided guiding use cases, history, which initially informed development of the initial Standard Genetics profile that is found in FHIR DSTU2. The same use cases also led to a second Project to develop a Sequence resource (“Develop FHIR sequence resource for Clinical Genomics”). A preliminary effort to address these issues has been explored and published in context of the Substitutable Medical Applications and Reusable Technologies ( SMART ) Platforms Project and described in an article (“ SMART on FHIR Genomics: Facilitating standardized clinico-genomic apps ”). Sequence is designed to hold genetic sequences in blocks relevant to actionable clinical decision-making. Extensions to Sequence address complex cases and can associate it with repositories for retrieving a patient’s full sequence data, such as those defined by GA4GH. Other changes include a suite of genetics profiles for other FHIR resources. In addition, the Observation-genetics profile adds new references so that an Observation can report genetics test results to be integrated into the EHR. There are also new genetics-extension profiles for DiagnosticReport, ProcedureRequest and FamilyMemberHistory, respectively, to extend them required to report genetics results. We have given all of these FHIR genetics profiles the suffix “-genetics” (e.g. “DiagnosticReport-genetics profile”). New profiles on top of DiagnosticReport have been created for reporting HLA genotyping results. On the following pages, we elaborate upon the rationale for the proposed design, introducing in some detail the following resource and profiles: A Sequence resource An Observation-genetics profile on Observation A DiagnosticReport-genetics profile on DiagnosticReport A ProcedureRequest-genetics profile on ProcedureRequest An HLA-genotyping-results profile on DiagnosticReport With these resource and profiles, FHIR can support a large set of clinical use cases (see Section 9 , 10 , and 11 ) and is thus positioned to address all emergent -omics use cases, including Next-Generation Sequencing ( NGS ). These tools are simple to implement, will optimize payload sizes, and help developers avoid redundant retrieval of data. Appendix 1 of this document shows how DSTU 2.0 can be mapped to the new additions to the resource. 10.8 Sequence Resource 10.8.1 Structure Diagram Name Flags Card. Type Description & Constraints Sequence Σ I DomainResource Information about a biological sequence + Only 0 and 1 are valid for coordinateSystem Elements defined in Ancestors: id , meta , implicitRules , language , text , contained , extension , modifierExtension identifier Σ 0..* Identifier Unique ID for this particular sequence. This is a FHIR-defined id type Σ 0..1 code aa | dna | rna sequenceType ( Example ) coordinateSystem Σ 1..1 integer Base number of coordinate system (0 for 0-based numbering or coordinates, inclusive start, exclusive end, 1 for 1-based numbering, inclusive start, inclusive end) patient Σ 0..1 Reference ( Patient ) Who and/or what this is about specimen Σ 0..1 Reference ( Specimen ) Specimen used for sequencing device Σ 0..1 Reference ( Device ) The method for sequencing performer Σ 0..1 Reference ( Organization ) Who should be responsible for test result quantity Σ 0..1 Quantity The number of copies of the seqeunce of interest. (RNASeq) referenceSeq Σ I 0..1 BackboneElement A sequence used as reference + Only +1 and -1 are valid for strand + GenomeBuild and chromosome must be both contained if either one of them is contained + Have and only have one of the following elements in referenceSeq : 1. genomeBuild ; 2 referenceSeqId; 3. referenceSeqPointer; 4. referenceSeqString; chromosome Σ 0..1 CodeableConcept Chromosome containing genetic finding chromosome-human ( Example ) genomeBuild Σ 0..1 string The Genome Build used for reference, following GRCh build versions e.g. 'GRCh 37' referenceSeqId Σ 0..1 CodeableConcept Reference identifier ENSEMBL ( Example ) referenceSeqPointer Σ 0..1 Reference ( Sequence ) A Pointer to another Sequence entity as reference sequence referenceSeqString Σ 0..1 string A string to represent reference sequence strand Σ 0..1 integer Directionality of DNA ( +1/-1) windowStart Σ 1..1 integer Start position of the window on the reference sequence windowEnd Σ 1..1 integer End position of the window on the reference sequence variant Σ 0..* BackboneElement Variant in sequence start Σ 0..1 integer Start position of the variant on the reference sequence end Σ 0..1 integer End position of the variant on the reference sequence observedAllele Σ 0..1 string Allele that was observed referenceAllele Σ 0..1 string Allele in the reference sequence cigar Σ 0..1 string Extended CIGAR string for aligning the sequence with reference bases variantPointer Σ 0..1 Reference ( Observation ) Pointer to observed variant information observedSeq Σ 0..1 string Sequence that was observed quality Σ 0..* BackboneElement An set of value as quality of sequence type Σ 1..1 code indel | snp | unknown qualityType ( Required ) standardSequence Σ 0..1 CodeableConcept Standard sequence for comparison FDA-StandardSequence ( Example ) start Σ 0..1 integer Start position of the sequence end Σ 0..1 integer End position of the sequence score Σ 0..1 Quantity Quality score for the comparison method Σ 0..1 CodeableConcept Method to get quality FDA-Method ( Example ) truthTP Σ 0..1 decimal True positives from the perspective of the truth data queryTP Σ 0..1 decimal True positives from the perspective of the query data truthFN Σ 0..1 decimal False negatives queryFP Σ 0..1 decimal False positives gtFP Σ 0..1 decimal False positives where the non-REF alleles in the Truth and Query Call Sets match precision Σ 0..1 decimal Precision of comparison recall Σ 0..1 decimal Recall of comparison fScore Σ 0..1 decimal F-score readCoverage Σ 0..1 integer Average number of reads representing a given nucleotide in the reconstructed sequence repository Σ 0..* BackboneElement External repository which contains detailed report related with observedSeq in this resource type Σ 1..1 code directlink | openapi | login | oauth | other repositoryType ( Required ) url Σ 0..1 uri URI of the repository name Σ 0..1 string Repository's name datasetId Σ 0..1 string Id of the dataset that used to call for dataset in repository variantsetId Σ 0..1 string Id of the variantset that used to call for variantset in repository readsetId Σ 0..1 string Id of the read pointer Σ 0..* Reference ( Sequence ) Pointer to next atomic sequence Documentation for this format 10.8.2 Description medicine. The Sequence resource is designed for next-generation sequencing data. Patients’ observed sequences should be represented by recording reference sequence id/string and detected variants. To specify how it proceed, here is a picture below: Sequence.coordinateSystem: This element shall be constrained into only two possible values: 0 for 0-based system and 1 for 1-based system. Below is the picture that could explain what’s the difference between these two systems: committee's work products include:

Here are two examples that clarify the usage in both cases (they represent same segment part):
  • 0-based example: here Source: XML , JSON 1-based example: here Source: XML , JSON Sequence.referenceSeq: Four optional ways are provided to represent reference sequence in Sequence resource: Sequence.referenceSeq.referenceSeqId: Reference sequence id in public database; Sequence.referenceSeq.referenceSeqString: Reference sequence string; Sequence.referenceSeq.referenceSeqPointer: Reference to observed sequence stored in another sequence entity; Sequence.referenceSeq.genomeBuild, Sequence.reference.chromosome: The combination of genome build and chromosome. The window selects a range from the reference sequence (or genome) that is used to define building block of a current sequence (e.g. Sequence resource instance 1). Sequence.referenceSeq.strand: Only two possible values can be made by strand, +1 for plus strand while -1 for minus strand. Since the directionality of the sequence string might be represented in different word in different omics scenario, below are simple example of how to map other expressions into its correlated value: Map to +1 Map to -1 5′-to-3′ direction 3′-to-5′ direction Watson Crick Sense Antisense Positive Negative Sequence.quality: Quality scores for bases in the sequence. Is is intended to be compliant with emerging regulatory needs needs (eg: those found at PrecisionFDA ). Sequence.variant: This complex element is used for encoding sequence. When the information of reference sequence and variants are provided, the observed sequence will be derived. 10.8.2.1 Internal Pointers Sequence.patient: This element points to a Patient identifier to show that this sequence is related to the same patient.

    Sequence.specimen: A pointer to specimen identifier, if needed. Sequence.device: A pointer to Device identifier which is used for describing sequencing method (such as chip id, chip manufacturer etc.) Sequence.pointer: A pointer to a Sequence instance for the next sequence block to build a sequence graph. 10.8.2.2 External Pointers Genomics Reporting icon Sequence.repository: This complex element is used to provide a clarifying structure, a base URL, and/or relevant IDs when referring to an external repository. GA4GH Repository Example. If the Sequence resource refers to a GA4GH repository for read info, references to a GA4GH full sequence dataset should conform to GA4GH data models and accessed via the GA4GH API. The URL of a GA4GH repository, ids of a GA4GH variant and read group are contained in the Sequence resource. The URL of a GA4GH repository is an api_base of a GA4GH server that could be called for sequence data. The GA4GH variant set is a collection of call sets and Implementation Guide: Standardizes the GA4GH call set is a collection of variant calls, typically for one sample. A variant call represents a determination of genotype with respect to that variant. VariantSet definition: A VariantSet is a collection reporting of variants and genomic variants, haplotypes, genotypes, variant calls intended to be analyzed together. CallSet definition: A CallSet is a collection of calls that were generated by the same analysis of the same sample. A read group is a collection of reads produced by a sequencer. A read group set typically models reads corresponding to one sample, sequenced one way, and aligned one way. The API reference of Google Genomics is a GA4GH repository built by Google annotations, and provides details of the data models, such as the resource representations. 10.8.3 Usage Examples 10.8.3.1 Different way to represent sequence record with variations We provide a detailed example to show how sequence resource can be used to represent record of observed sequence by different method. more.

    The diagram above describes 4 optional ways provided in the Sequence resource to encode sequencing data. Here are the corresponding examples By referenceSeqId Source: XML , JSON , TURTLE By referenceSeqString Source: XML , JSON , TURTLE By referenceSeqPointer Source: XML , JSON , TURTLE
  • By Genomebuild+chromosome Source: XML , JSON , TURTLE 10.8.3.2 Example from precision FDA We provide one example to show how precision FDA vcf data can be upload and comform FHIR specification, and how quality in sequence resource is represented by comparison between a reference sequence and the observed sequence. Source: XML , JSON , Turtle . 10.8.3.3 Complex Variation example We provide one example to show how a complex variant can be represented with the help of cigar. The deletion, insertion and mutation is represented in characters along with the number of repetition. Source: XML , JSON , Turtle . 10.8 Observation-genetics Profile 10.8.1 Structure Diagram Name Flags Card. Type Description & Constraints Observation 0 .. * observation-geneticsDNASequenceVariantName 0 .. 1 CodeableConcept DNA sequence variant URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsDNASequenceVariantName Binding: ???? ( preferred ) observation-geneticsDNAVariantId 0 .. 1 CodeableConcept DNA sequence variant ID URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsDNAVariantId observation-geneticsDNASequenceVariantType 0 .. 1 CodeableConcept DNA sequence variant type URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsDNASequenceVariantType observation-geneticsAminoAcidChangeName 0 .. 1 CodeableConcept Amino acid change URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsAminoAcidChangeName Binding: ???? ( preferred ) observation-geneticsAminoAcidChangeType 0 .. 1 CodeableConcept Amino Acid Change Type URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsAminoAcidChangeType observation-geneticsGene 0 .. 1 CodeableConcept HGNC gene symbol URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsGene Binding: ???? ( preferred ) observation-geneticsDNARegionName 0 .. 1 string DNA region name URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsDNARegionName observation-geneticsAlleleName 0 .. 1 CodeableConcept Name of allele URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsAlleleName Binding: ???? ( preferred ) observation-geneticsAllelicState 0 .. 1 CodeableConcept The level of occurrence of a single DNA sequence variant within a set of chromosomes: Heteroplasmic / Homoplasmic / Homozygous / Heterozygous / Hemizygous URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsAllelicState observation-geneticsAllelicFrequency 0 .. 1 decimal Allele frequency URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsAllelicFrequency observation-geneticsCopyNumberEvent 0 .. 1 CodeableConcept Copy number variation URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsCopyNumberEvent observation-geneticsGenomicSourceClass 0 .. 1 CodeableConcept Genomic source class URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsGenomicSourceClass observation-geneticsPhaseSet 0 .. 1 uri Phase set identifier (UUID/OID) URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsPhaseSet observation-geneticsSequence 0 .. * Reference ( Sequence ) Sequence URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsSequence observation-geneticsInterpretation 0 .. 1 Reference ( Observation ) Clinical interpretations for variant URL: http://hl7.org/fhir/StructureDefinition/observation-geneticsInterpretation Documentation for this format 10.8.2 Description

    The Observation-genetics profile MolecularDefinition Observation-genetics profile is used to interpret variants from sequence resource. Clinical usage may need more specific representation of variant at locus or structural variant in whole genome. Some of the attributes of the profile follow: Resource: The observation-geneticsSequence extension will refer to the Sequence MolecularDefinition resource represents molecular entities (e.g., nucleotide or protein sequences) for sequence information related to this variant. The observation-geneticsInterpretation extension will refer to an Observation instance which contains both clinical interpretations for the variant described. The code, effective[x], issued, performer, method, specimen elements can be used to describe how the genetic observation (variant and sequence data) non-clinical use cases, including translational research. The resource is obtained. Other extensions are used to describe attributes of this variant such as Genomics Source Class, Amino Acid Change Type, etc. These are mappings from v2 and lonic code reference with details can be found in this list . Additional Observations instance will be created for variant's further analysis. For example, Observation.component element will be used for knowledge-based interpretations of the sequence variant. Here are some examples for the component.code. LOINC Code LOINC Element Name Comments 51963-7 Medication Assessed A coded medication accessed definitional, in a pharmacogenetic test (recommend RxNorm). 51967-8 Genetic disease assessed A coded disease that is associated with the region of DNA covered by the genetic test (recommend SNOMED). 53037-8 Genetic Disease Sequence Variant Interpretation Interpretation of the pathogenicity of the DNA Sequence Variant in the context of the assessed genetic disease. 53040-2 Drug Metabolism Sequence Variant Interpretation Predicted phenotype for drug efficacy. A sequence variant interpretation value known to allow (responsive) or prevent (resistant) the drug to perform. 51961-1 Drug Efficacy Sequence Variant Interpretation Predicted phenotype for ability of drug to bind to intended site in order to deliver intended effect. A Sequence Variant interpretation value known to allow (responsive) or prevent (resistant) the drug to perform. In the meantime, the related element in this Observation instance will point to Observaiton-genetics profile to show these clinical interpretations are further analysis for the variant. (For example, sequence variant has its pointer back to the observation, see PGx example ) 10.8.3 Usage Examples 10.8.3.1 An Observation-genetics instance and its two related Observation instances for interpretations We provide an example of an Observation-genetics instance which records a variant detected in the patient. (we call this example A) Source: XML , JSON , Turtle . An example of an Observation instance which records knowledge-based clinical interpretations for the variant represented in A. Source: XML , JSON , Turtle . An example of an Observation instance which records PCR validation test for the variant in A. Source: XML , JSON , Turtle . 10.8.3.2 Phenotype, Diplotype it focuses on discrete, computable, and Haplotye We provide the following examples to reveal how PGx semantically expressive data can be harmonized within structures that reflect the FHIR specification. Detailed discussion will be put here. Phenotype Source: XML , JSON , TURTLE Diplotype Source: XML , JSON , TURTLE Haplotype Source: XML , JSON , TURTLE 10.8 DiagnosticReport-genetics Profile 10.8.1 Structure Diagram Name Flags Card. Type Description & Constraints DiagnosticReport 0 .. * codedDiagnosis 0 .. 0 DiagnosticReport-geneticsAssessedCondition 0 .. * Reference ( Condition ) AssessedCondition URL: http://hl7.org/fhir/StructureDefinition/DiagnosticReport-geneticsAssessedCondition DiagnosticReport-geneticsFamilyMemberHistory 0 .. * Reference ( FamilyMemberHistory ) FamilyHistory URL: http://hl7.org/fhir/StructureDefinition/DiagnosticReport-geneticsFamilyMemberHistory DiagnosticReport-geneticsAnalysis 0 .. * (Complex) Analysis URL: http://hl7.org/fhir/StructureDefinition/DiagnosticReport-geneticsAnalysis Documentation for this format This DiagnosticReport-genetics is built on top of DiagnosticReport. The new profile is used to describe a genetics test report. The result element in DiagnosticReport will refer to genomic domain. Because the Observation resource that can lead to a bundle of genetic observations. And focuses on the element of code, effective[x], issued, performer, request, molecular entities rather than specimen are be used to describe the details of the genetic test. Extensions about AssessedCondition and FamilyMemberHistory are added. Overall, this profile extends the DiagnosticReport resource to enable reporting of structured genetic test results. In addition, source or annotated knowledge, it denotes condition context for genetic testing, which may influence reported variants and interpretations for large genomic testing panels. The DiagnosticReport-genetics profile contains two extensions referring to other resources/profiles supports both patient/participant-specific use cases and one complex extension. AssessedCondition is used to denote condition context for genetic testing, which may influence reported variants population-based data, and interpretation for large genomic testing panels. It refers to the Condition resource. FamilyMemberHistory are significant health events both human and conditions for one or more persons related to the patient. It refers to the FamilyMemberHistory-Genetic profile. non-human data.

  • Analysis provides knowledge-based interpretation of overall results of tests performed on patients. Examples for analysis.code: LOINC Code LOINC Element Name Comments 51968-6 Genetic Disease Analysis Overall Interpretation Interpretation of all identified DNA Sequence variants along with any known clinical information for the benefit of aiding clinicians in understanding the results overall in either the context of diagnosis or increased risk of disease. 51964-5 Drug Efficacy Analysis Overall Interpretation Overall predicted phenotype for drug efficacy for all DNA Sequence Variants identified in a single case. 51971-0 Drug metabolism analysis overall interpretation Overall predicted phenotype for drug metabolism for all DNA Sequence Variants identified in a single case. 10.8.2 Usage Examples

    An example of a genetic test report Molecular Definition Implementation Guide for a patient with FamilyHistory. Source: XML , JSON , Turtle . An example of a comprehensive bone marrow report. Source: XML , JSON , Turtle . 10.8 ProcedureRequest-genetics profile 10.8.1 Structure Diagram Molecular Data Types icon A complex extension is added on top of the ProcedureRequest resource. Here is the structure of the extension: Name Flags Card. Type Description & Constraints ProcedureRequest 0 .. * procedurerequest-geneticsItem 0 .. * (Complex) The items the orderer requested URL: http://hl7.org/fhir/StructureDefinition/procedurerequest-geneticsItem Documentation for this format 10.8.2 Description To describe an order requested sequence variants detection. User must set up the code for the request and they can also refer to the corresponding sequence instance for emerging product that variant. 10.8.3 Usage Example 10.8.3.1 An order for genetics test Here is a diagnostic request includes profiles for testing 185delAG variant. The mother structured representation of the patient received results from a mutation panel (eg. MyRisk from Myriad) and she has a BRCA1 185delAG mutation. The clinician the would like to request to test the patient only for an 185delAG mutation. In this case, the diagnostic request for the patient will specify the sequence variant - 185delAG. 10.8 HLA genotyping results Profile Human leukocyte antigen (HLA) genotyping is fundamental for research and clinical practice in immunogenetics and histocompatibility. Pointers to external locations refer to registered methods, raw NGS reads, and reference standards can be conveyed in this profile. Information about allele assignment including ambiguous results and the allele database used for assignments is stored in extensions. The structure of the HLA typing report in this profile attempts to follow the principles outlined in the Minimum Information for ReportIng Next-generation sequence Genotyping (MIRING). These principles were identified through a series of meetings with international group of stakeholders in the application of Next Generation Sequencing (NGS) technology for genotyping the HLA and KIR loci as well as other immune-related loci (http://igdawg.org/ngs.html). MIRING describes eight principles, described in detail in Human Immunology. 2015 Dec; 76(12):954-962 . These include detailed metadata about: MIRING Annotation Reference Context Full Genotype Consensus Sequence Novel Polymorphisms Platform Documentation Read Processing Documentation Primary Data (see the publication above for details about each) These principles were implemented in a technical specification by extending an existing XML based format for exchanging histocompatibility and immunogenetic genotyping data called Histoimmunogenetics Markup Language (HML) to include results from NGS methodologies (https://bioinformatics.bethematchclinical.org/hla-resources/hml/). The resulting schema may be found in https://schemas.nmdp.org/. The National Marrow Donor Program (NMDP)/Be The Match uses this format for reporting HLA genotyping from potential donors and for patients needing stem cell transplants. Both MIRING and HML were used to inform mapping data elements to FHIR resources concepts such as Patient, Specimen, Sequence, Observation-Genetic Profile, and DiagnosticReport where possible. Several additional data elements were needed specifically for this use case, resulting in the development of a specific profile for reporting HLA genotyping results (Diagnostic Report Profile for HLA Genotyping Results). Minimum information for reporting next generation sequence genotyping (MIRING): Guidelines for reporting HLA and KIR genotyping via next generation sequencing (see here ) Histoimmunogenetics Markup Language 1.0: Reporting Next Generation Sequencing-based HLA and KIR Genotyping (see here ) 10.8.1 Structure Diagram of HLA genotyping results Profile Name Flags Card. Type Description & Constraints extension 0..* Extension URL = http://hl7.org/fhir/StructureDefinition/hla-genotyping-results-haploid haploid: haploid. Use on element: DiagnosticReport locus 0..1 CodeableConcept gene region. type 0..1 CodeableConcept haploid type. method 0..1 CodeableConcept haploid method. Documentation for this format Both hla-genotyping-results-glstring and hla-genotyping-results-haploid are complex extensions. The development of these extensions were informed from the allele-assignment structure found in HML. While allele assignment for individual loci can be reported in an Observation, here they are used to summarize the assignments at a report level. Two methods may be used for reporting HLA allele-assignments: Haploid and GL String. Structure of hla-genotyping-results-haploid: Name Flags Card. Type Description & Constraints extension 0..* Extension URL = http://hl7.org/fhir/StructureDefinition/hla-genotyping-results-haploid haploid: haploid. Use on element: DiagnosticReport locus 0..1 CodeableConcept gene region. type 0..1 CodeableConcept haploid type. method 0..1 CodeableConcept haploid method. Documentation for this format Haploid reporting is a method that is used to report an individual allele, or a list of possible alleles if the results are ambiguous, using NMDP Multiple Allele Codes (MAC) which is a shorthand for describing allele ambiguity (https://bioinformatics.bethematchclinical.org/hla-resources/allele-codes/). MACs are widely used for reporting HLA typing results because they are able to report long allele lists in a small amount of space, but the system has a number of shortcomings ( Tissue Antigens. 2013 Aug;82(2):106-12 ). When reporting data using haploid, typical use is one or two haploid elements for a particular locus, but possibly more if multiple loci are covered (ex: two HLA-DRB1 haploids + one HLA-DRB3 haploid). Within Haploid, Method indicates whether the general methodology is DNA based typing (e.g., Sequence Specific Primers (SSP), Sequence Specific Oligonucleotide Probes (SSOP), or Sequence Based Typing (SBT)), or SER which indicates serology based methods. Example of using two hla-genotyping-results-haploid extensions to report a HLA-A genotype of HLA-A*01:AB and HLA-A*02:MN which expands to HLA-A*01:01/HLA-A*01:02 and HLA-A:02:01/HLA-A:02:02/HLA-A:02:03 <extension url="http://hl7.org/fhir/StructureDefinition/hla-genotyping-results-haploid" > <extension url=”locus”> <valueCodeableConcept> <coding> <system value="http://www.genenames.org"/> <code value="4931"/> <display value="HLA-A"/> </coding> <text value="HLA-A"/> </valueCodeableConcept> </extension> <extension url=”type”> <valueCodeableConcept> <coding> <system value="https://bioinformatics.bethematchclinical.org/hla-resources/allele-codes/"/> <code value="AB"/> <display value="01/02"/> </coding> <text value="HLA-A*01:AB"/> </valueCodeableConcept> </extension> <extension url=”method”> <valueCodeableConcept> <text value=”DNA”/> </valueCodeableConcept> </extension> </extension> <extension url="http://hl7.org/fhir/StructureDefinition/hla-genotyping-results-haploid" > <extension url=”locus”> <valueCodeableConcept> <coding> <system value="http://www.genenames.org"/> <code value="4931"/> <display value="HLA-A"/> </coding> <text value="HLA-A"/> </valueCodeableConcept> </extension> <extension url=”type”> <valueCodeableConcept> <coding> <system value="https://bioinformatics.bethematchclinical.org/hla-resources/allele-codes/"/> <code value="AB"/> <display value="01/02/03"/> </coding> <text value="HLA-A*02:MN"/> </valueCodeableConcept> </extension> <extension url=”method”> <valueCodeableConcept> <text value=”DNA”/> </valueCodeableConcept> </extension> </extension> Because of limitations with MAC, another method called GL Strings was developed that encodes the results in a text string with hierarchical set of operators to describe the relationships between alleles, lists of possible alleles, phased alleles, genotypes, lists of possible genotypes, and multilocus unphased genotypes, without losing typing information or increasing typing ambiguity. ( Tissue Antigens. 2013 Aug;82(2):106-12 ). The structure of HLA-genotyping-results-glstring: Name Flags Card. Type Description & Constraints extension 0..1 Extension URL = http://hl7.org/fhir/StructureDefinition/hla-genotyping-results-glstring glstring: glstring. Use on element: DiagnosticReport url 0..1 uri glstring using a URI reference. text 0..1 string glstring using inline data. Documentation for this format While the string format is easily parsed into separate components to be rendered for user viewing, GL Strings by themselves are potentially quite long and difficult to read. It often advantageous to point to a URI which may return the GL String on demand to avoid manual data entry. This is available through the URI element in this extension. Example of using the hla-genotyping-results-glstring to report a GL String in both text and URI formats <extension url="http://hl7.org/fhir/StructureDefinition/hla-genotyping-results-glstring"> <extension url=”text”> <valueString value="HLA-A*01:01:01:01/HLA-A*01:02+HLA-A*02:01:02/HLA-A*02:02:02/HLA-A*02:03:01"/> </extension> <extension url=”uri”> <valueUri value="https://gl.nmdp.org/imgt-hla/3.23.0/genotype/1h"/> </extension> </extension> Whether reporting in Haploid or GL String formats, it is important to identify the version of the IMGT/HLA allele database, as new HLA alleles are constantly being discovered and allele assignment is based on the known alleles at the time, and so results may need to be reinterpreted later. This is done through the Allele Database element. Structure of hla-genotyping-results-allele-database Name Flags Card. Type Description & Constraints extension 0..1 CodeableConcept icon URL = http://hl7.org/fhir/StructureDefinition/hla-genotyping-results-allele-database allele-database: , Allele Database. Use on element: DiagnosticReport Documentation for this format Example of using hla-genotyping-results-allele-database to report using the IMGT/HLA database, version 3.23 <extension url="http://hl7.org/fhir/StructureDefinition/hla-genotyping-results-allele-database"> <valueCodeableConcept> <coding> <system value="http://www.ebi.ac.uk/ipd/imgt/hla/"/> <version value="3.23"/> </coding> <text value="IMGT/HLA 3.23"/> </valueCodeableConcept> </extension> Overall methodology may be reported using hla-genotyping-results-method. Here a codeable concept may be used to refer to method entered into a public registry, such as the NCBI Genetic Test Registry, or a local private registry. Structure of hla-genotyping-results-method Name Flags Card. Type Description & Constraints extension 0..1 CodeableConcept icon URL = http://hl7.org/fhir/StructureDefinition/hla-genotyping-results-method method: The platform, methodology , and software applied at the time of the genotyping. Use on element: DiagnosticReport Documentation for this format Example of hla-genotyping-results-method to report a lab test registered in the NCBI Genetic Test Registry <extension uri="http://hl7.org/fhir/StructureDefinition/hla-genotyping-results-method"> <valueCodeableConcept> <coding> <system value="http://www.ncbi.nlm.nih.gov/gtr/"/> <code value="GTR000000000.0"/> </coding> <text value=”NGS based HLA-A genotyping” </valueCodeableConcept> </extension> 10.8.2 Usage Example Variation icon Example of a HLA genotyping report that was requested in a Diagnostic Request, with results for HLA-A, HLA-B, HLA-C loci, by Sequence Based Typing (SBT) of exons 2 and 3, using Next Generation Sequencing technologies, allele assignment based on the IMGT/HLA database version 3.23, reported as a multilocus unphased genotype using GL Strings, and with genotyping results for individual loci available in separate Observations Source: XML , JSON Haplotype icon , Turtle and Genotype icon . In the above example, three Observations are referenced, each containing the details surrounding the genotyping of each gene/locus. Those observations would further refer to other observations (using Observation.related) that point to phased exon sequences which are the basis for individual allele assignment. This strategy guide is illustrated in the following figure for one gene, and sequencing two exons for each allele. Note that references from DiagnosticReport and Observation back to Patient/Donor and Specimen are not shown for clarity, although we would include them work in the resource instances. 10.8 Relationship among Sequence resource and genetics profiles 10.8.1 Pointers to Sequence resource Sequence resource is used to transmit progress and represent sequencing data. In FHIR Genomics, there are several genetics profiles containing internal pointers to Sequence resource for genetic data reporting. Here is the summary: Sequence.pointer: A bundle of Sequence instances can be connected by Sequence.pointer to build sequence graph described in Section 3. Sequence.pointer will point evolve to the next sequence block. represent additional concepts.

  • Sequence extension in Observation-genetics profile: Observation-genetics profile is used to report a genetic variant found in patients. Sequence extension contains a pointer to Sequence identifier which has related sequencing read info. It will provide reference/observed allele information and quality scores for each base/sequence block. 10.8.2 Pointer to Observation resource (based on genetics profile) GenomicStudy Observation-genetics based Observation resource is used for interpretative genetic data. Sequence resource and genetics profiles will use internal pointers to Observation-genetics-profile based Observation instance for variant report. Sequence.observation: A pointer to genetics Observation instance which is used for interpretations of this sequence block. Interpretations are generally about genetic variant found in this sequence block. DiagnosticReport.result: A pointer to Observation instance. This element is used for reporting genetic result. Item extension in ProcedureRequest-genetics profile: It is used to describe the genetic test order. FamilyMemberHistory: Resource: A pointer to genetics Observation instance to report genetic test results of family member 10.8.3 Observation vs. Sequence Sequence is used for raw sequencing data while genetic-profile-based Observation resource is used for reporting interpretative genetic that aims at delineating relevant information (eg. DNA/amino acid variant detected in the patient). Although both Sequence and Observation-genetics profiles contain variant info, they are used differently: Sequence.variant is used for encoding the sequence block; the Observation-genetics profile is mainly used for a variants test result or interpretations of raw data in Sequence resource. 10.8.4 Usage example This picture depicts the logical relationship among these resources. And the definition of pointers are described above: Here are the details and examples mentioned above. Resource Details of data structures and pointers Links of resources example Sequence Sequence Data Structure Example Here Observation Observation Data Structure Example Here ProcedureRequest ProcedureRequest Data Structure Example Here DiagnosticReport DiagnosticReport Data Structure Example Here Here is a specific use case to depict the whole story of FHIR in the clinical genomics setting: a ProcedureRequest is requested, then a Diagnosticreport are reported. Two Sequence instance, two Observation-haplotype instance, a Observation-diplotype and a Observation-phenotype for further interpretation are also created. (You can see the xml code and json code if you click the link.) Haplotype: A haplotype is a set of DNA variations, or polymorphisms, that tend to be inherited together. genomic study. A haplotype can refer to a combination of alleles genomic study might comprise one or to a set of single nucleotide polymorphisms (SNPs) found on the same chromosome. Diplotype: A diplotype is defined as more analyses, each serving a specific combination of two haplotypes. Genotype: A genotype is an individual’s collection of genes. Phenotype: A phenotype is the composite of an organism’s observable characteristics or traits, such as its morphology, development, biochemical or physiological properties, behavior and products of behavior. You can see the relationship among these resources in following picture: 10.8 HL7 Domain Analysis Use Cases Simulated use of the proposed Sequence resource and profiles on other FHIR resources are shown for many of the examples in Section 5 – Use Case Scenarios purpose. These analyses may vary in the HL7 Domain Analysis Model (DAM): Clinical Genomics, Release 1, September 2014 Informative Ballot . We show use of the FHIR design we are proposing for these cases: Specimen Identification Get references to all variants obtained from germline analysis. Explore antibacterial drug resistance over time (non-patient DNA) Clinical Sequencing – Germline Testing Cancer Profiling Decision Making Tools – Family History and Drug Dosage Calculators Today clinicians translate (i.e. manually re-enter) genetic data into tools for decision making. This includes family history tools and drug dosage calculators. In the future, this data will automatically be incorporated into clinical decision making tools. Get pharmacogenomic reporting and disease risk method (e.g., karyotyping, CNV, or diagnosis associated with variant Public Health Clinical and Research Data Warehouses SNV detection), performer, software, devices used, or regions targeted.

    10.8.1 Specimen Identification Germline testing for biomarkers/mutations (usually inherited) Tumor testing for biomarkers/mutations (somatic / tumor specific) Pediatric Testing Infectious Disease Testing
10.8.1.1 Get references to all variants obtained from germline analysis GET /Observation? _profile=http://hl7.org/fhir/StructureDefinition/observation-genetics& GenomicSourceClass=http://loinc.org|LA6683-2 *Return a bundle of genetics-profile-based Observation instances 10.8.2 Clinical Sequencing – Germline Testing For a chart review, get references to all DNA sequences related to mutations with an interpretation “Unknown Significance” GET /Observation? subject=123& component-code-value-[x]= http://loinc.org|53037-8$LA6682-4

53037-8: LOINC code for “Genetic disease sequence variant interpretation” LA6682-4: LOINC answer code for “Unknown Significance”. 10.8.3 Cancer Profiling The goal of this profile methodology is to get references from all variants obtained from somatic analysis. Changes in the population of cells with particular mutations will change overtime as well as in conjunction with events such as therapy. For instance, targeted chemotherapy may kill a specific population Uses of cancer cells with specific mutations and other cancer cell populations may survive and continue to divide. Therefore, clearly annotating these specimens as somatic variants and capturing annotations related to a time relevant to a treatment timeline may be critical for analysis. GET /Observation? _profile=http://hl7.org/fhir/StructureDefinition/observation-genetics& GenomicsSourceClass=http://loinc.org|LA6684-0& date=2015-07-04& subject=123 10.8.4 Decision Making Tools – Family History and Drug Dosage Calculators Today clinicians translate (i.e. manually re-enter) genetic data into tools for decision making. This includes family history tools and drug dosage calculators. In the future, this data will automatically be incorporated into clinical decision making tools. Get family history related to one observation: GET /DiagnosticReport? _profile=http://hl7.org/fhir/StructureDefinition/diagnosticreport-genetic& subject=123 10.8.4.1 Get pharmacogenomic reporting and disease risk or diagnosis associated with variant GET /Observation? _profile=http://hl7.org/fhir/StructureDefinition/observation-genetics& subject=123& Interpretation.component-code= http://loinc.org|51963-7 51963-7 : LOINC code for “Medication Assessed ” 10.8.5 Public Health Today Registrars manually translate clinical data into public health reporting systems. This data is used to monitor and improve public health (e.g. surveillance FHIR artifacts and clinical research). In the future, this data will be extracted from the EHR in an automated (or semi-automated) fashion. For a breast cancer clinical other genomic study, get all genetic-profile-based observations of patients with breast cancer: GET /DiagnosticReport? _profile=http://hl7.org/fhir/StructureDefinition/diagnosticreport-genetic& AssessedCondition.code=http://snomed.info/sct|254837009 10.8.6 Clinical and Research Data Warehouses Health data warehousing should persist data in its standardized formats, while allowing users to export subsets of the data in the warehouse into multiple ‘data marts’, optimized for specific use cases, analysis type or reporting needs. Get all genetic-profile-based observations of patients with the variant c.181T>G GET /Observation? _profile=http://hl7.org/fhir/StructureDefinition/observation-genetics& DNAVariantID=http://www.ncbi.nlm.nih.gov/projects/SNP|rs58238560 10.8 Other Genomics Use Cases During the development of the FHIR Genomics design, CGWG participants have commented on the earlier use cases and/or proposed new use cases. In this section, we list describe of these new cases and demonstrate how the proposed design will address them. 10.8.1 Get a patient’s family members genetics report This example is proposed by Kevin Hughes. Family history is useful for clinicians to know more about the condition of the patient. Get /FamilyMemberHistory? _profile=http://hl7.org/fhir/StructureDefinition/familymemberhistory-genetic& patient=123 10.8.2 Panel Search for results from nephrotic syndrome panel Get /DiagnosticReport& _profile=http://hl7.org/fhir/StructureDefinition/diagnosticreport-genetic& code=N0336& patient=123 10.8.3 Sequence Test Metrics 10.8 Clinical Genomic Apps The idea for a Sequence resource grew out, in part, the SMART Platforms Project, which explored creating clinical genomic apps to integrated traditional EMR clinical data and genomic data to show data visualization and analysis, including CDS that depended upon both types of data. Below are a couple of examples. Several apps have already been designed including Genomics Advisor, SMART Precision Cancer Medicine, and Diabetes Bear EMR. Below, one of these apps will can be described. To include other apps in this section, please feel free to add a note on it and how it uses FHIR/Genomics calls. 10.8.1 Genomics Advisor The SMART on FHIR Genomics Advisor was an app incorporating genomics data to show risk of disease, drug susceptibility, and related conditions based upon genotype. Technically, this app was architected (see below) by combining data from independent data services, a SMART on FHIR clinical server for clinical information and one for a SMART on FHIR Genomics data server for genomic data. The set of FHIR API calls that are necessary to support this app are shown below: The presentation of the app looks like this: 10.8 Appendix 1: From DSTU2 Genomics to STU3 found here icon The table shows how the data elements in the DSTU2 Observation resource as extended by the Standard Genetics Profile would be mapped to the new Sequence resource.

DSTU2 Standard Genetics profile on Observation Observation-genetics profile Maps to Sequence (Proposed) geneticsGenomeBuild Sequence extension referenceSeq.genomicsBuild geneticsChromosome Sequence extension referenceSeq.chromosome geneticsGenomicsStart Sequence extension variant.start geneticsGenomicsStop Sequence extension variant.end geneticsReferenceAllele Sequence extension variant.referenceAllele geneticsObservedAllele Sequence extension variant.observedAllele geneticsSpecies Sequence extension specimen geneticsAllelicState Allelic State extension geneticsAllelicFrequency Allelic Frequency extension geneticsReadCoverage Sequence extension readCoverage geneticsCopyNumberEvent Copy number event extension geneticsTranscriptReferenceSequenceId Transcript reference sequence identifier extension geneticsProteinReferenceSequenceId Protein reference sequence identifier geneticsCIGAR Sequence extension variant.cigar geneticsVariationId DNA variation id extension geneticsVariationType DNA sequence variation type extension geneticsAminoAcidChange Amino acid change extension geneticsAminoAcidChangeType Amino acid change type extension geneticsGene Gene extension geneticsDNARegionName DNA region name extension geneticsGenomicSourceClass Genomic source class extension